We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

50 hedge funds and large institutions have $171M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $151M → $171M (+$20.1M)

0% more funds holding

Funds holding: 50 → 50 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $518K

Holders
50
Holders Change
–
Holders Change %
0%
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
5
Increased
15
Reduced
16
Closed
5
Calls
–
Puts
$518K
Net Calls
-$518K
Net Calls Change
-$119K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.8M
2
GTC
Ghost Tree Capital
New York
+$2.27M
3
NC
Nexthera Capital
New York
+$2.27M
4
ACA
Avoro Capital Advisors
New York
+$2.24M
5
ACH
ArrowMark Colorado Holdings
Colorado
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$7.71M
2
FCMI
Foresite Capital Management III
California
-$3.27M
3
ACP
Acuta Capital Partners
California
-$2.96M
4
FCMI
Foresite Capital Management II
California
-$1.35M
5
SAM
Senzar Asset Management
New York
-$425K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$584K +$206K +11,900 +60%
Northern Trust
27
Northern Trust
Illinois
$547K +$38.7K +2,235 +8%
AA
28
ALPS Advisors
Colorado
$510K -$48.8K -2,814 -9%
Victory Capital Management
29
Victory Capital Management
Texas
$469K +$440K +25,360 New
PPA
30
Parametric Portfolio Associates
Washington
$427K – – –
Swiss National Bank
31
Swiss National Bank
Switzerland
$422K – – –
Morgan Stanley
32
Morgan Stanley
New York
$279K -$44.7K -2,578 -15%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$271K -$149K -8,599 -37%
DCM
34
DAFNA Capital Management
California
$267K – – –
Bank of New York Mellon
35
Bank of New York Mellon
New York
$259K -$19.3K -1,112 -7%
ProShare Advisors
36
ProShare Advisors
Maryland
$252K -$42.7K -2,464 -15%
Goldman Sachs
37
Goldman Sachs
New York
$229K +$215K +12,387 New
Bank of America
38
Bank of America
North Carolina
$146K -$27.3K -1,576 -17%
Deutsche Bank
39
Deutsche Bank
Germany
$136K -$81.5K -4,701 -39%
VanEck Associates
40
VanEck Associates
New York
$118K +$399 +23 +0.4%
Group One Trading
41
Group One Trading
Illinois
$84K -$3.47K -200 -4%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$67K – – –
Citigroup
43
Citigroup
New York
$65K +$15.8K +910 +35%
Barclays
44
Barclays
United Kingdom
$62K +$53.9K +3,112 +1,111%
PCM
45
Penserra Capital Management
California
$33K +$7.75K +447 +33%
UBS Group
46
UBS Group
Switzerland
$28K +$1.72K +99 +7%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$13K – – –
IWMPD
48
Integrated Wealth Management (Palm Desert)
California
$9K – – –
FWM
49
Focused Wealth Management
New York
$1K – – –
TCIM
50
TIAA CREF Investment Management
New York
$161 – – –
1
2
3

NDRM Hedge Fund Activity: Q3 2016 in Review

50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2016, worth a combined $171M — up 13% from $151M a quarter earlier.

Fund positioning in NDRM was balanced in Q3 2016: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 16 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $4.8M. The largest seller was GMT Capital, cutting an estimated $7.71M.

  • 50 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $171M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2016, up 13% quarter-over-quarter.
  • 5 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2016 and 5 closed out, a net change of 0 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2016 was Adage Capital Partners, an estimated $4.8M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2016 was GMT Capital, an estimated $7.71M sold.

Based on aggregated 13F filings for Q3 2016.